These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32321630)

  • 1. Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease.
    Shirai T; Furuuchi K; Fujiwara K; Nakamoto K; Tanaka Y; Ishii H; Yoshiyama T; Yoshimori K; Takizawa H; Sasaki Y; Kurashima A; Ohta K; Morimoto K
    Respir Med; 2020 May; 166():105955. PubMed ID: 32321630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus precipitating antibody in patients with Mycobacterium avium complex lung disease: A cross-sectional study.
    Suzuki S; Asakura T; Namkoong H; Okamori S; Yagi K; Kamata H; Uwamino Y; Funatsu Y; Nakano Y; Nishimura T; Ishii M; Ebihara T; Betsuyaku T; Hasegawa N
    Respir Med; 2018 May; 138():1-6. PubMed ID: 29724379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease.
    Furuuchi K; Ito A; Hashimoto T; Kumagai S; Ishida T
    J Infect Chemother; 2018 Aug; 24(8):654-659. PubMed ID: 29705392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease.
    Furuuchi K; Ito A; Hashimoto T; Kumagai S; Ishida T
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):91-98. PubMed ID: 28920166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
    Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y
    BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease.
    Takasaka N; Hosaka Y; Fukuda T; Shinfuku K; Chida K; Shibata S; Kojima A; Hasegawa T; Yamada M; Yamanaka Y; Seki A; Seki Y; Ishikawa T; Kuwano K
    Respir Med; 2022 Feb; 192():106738. PubMed ID: 35051876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of anti-glycopeptidolipid-core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung disease.
    Matsuda S; Asakura T; Morimoto K; Suzuki S; Fujiwara K; Furuuchi K; Osawa T; Namkoong H; Ishii M; Kurashima A; Tatsumi K; Ohta K; Hasegawa N; Sasaki Y
    Respir Med; 2020 Sep; 171():106086. PubMed ID: 32917357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease.
    Hayashi M; Takayanagi N; Kanauchi T; Miyahara Y; Yanagisawa T; Sugita Y
    Am J Respir Crit Care Med; 2012 Mar; 185(5):575-83. PubMed ID: 22199005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis.
    Zoumot Z; Boutou AK; Gill SS; van Zeller M; Hansell DM; Wells AU; Wilson R; Loebinger MR
    Respirology; 2014 Jul; 19(5):714-22. PubMed ID: 24690015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis.
    Kitasato Y; Tao Y; Hoshino T; Tachibana K; Inoshima N; Yoshida M; Takata S; Okabayashi K; Kawasaki M; Iwanaga T; Aizawa H
    Respirology; 2009 Jul; 14(5):701-8. PubMed ID: 19659648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease.
    Naito M; Kurahara Y; Yoshida S; Ikegami N; Kobayashi T; Minomo S; Tachibana K; Tsuyuguchi K; Hayashi S; Suzuki K
    Respir Investig; 2018 Jul; 56(4):326-331. PubMed ID: 29764749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex cytokine analysis in Mycobacterium avium complex lung disease: relationship between CXCL10 and poor prognostic factors.
    Bamba Y; Moro H; Aoki N; Koizumi T; Ohshima Y; Watanabe S; Sakagami T; Koya T; Takada T; Kikuchi T
    BMC Infect Dis; 2019 Mar; 19(1):263. PubMed ID: 30885152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and prognosis of chronic pulmonary aspergillosis.
    Ohba H; Miwa S; Shirai M; Kanai M; Eifuku T; Suda T; Hayakawa H; Chida K
    Respir Med; 2012 May; 106(5):724-9. PubMed ID: 22349065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease.
    Kobashi Y; Fukuda M; Yoshida K; Miyashita N; Niki Y; Oka M
    Respirology; 2006 Nov; 11(6):809-13. PubMed ID: 17052313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung disease.
    Pan SW; Shu CC; Feng JY; Chien JY; Wang JY; Chan YJ; Yu CJ; Su WJ
    Clin Microbiol Infect; 2021 Mar; 27(3):467.e9-467.e14. PubMed ID: 32360207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.
    Chan JF; Lau SK; Wong SC; To KK; So SY; Leung SS; Chan SM; Pang CM; Xiao C; Hung IF; Cheng VC; Yuen KY; Woo PC
    Emerg Microbes Infect; 2016 Apr; 5(4):e37. PubMed ID: 27094904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
    Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
    Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of anti-glycopeptidolipid-core IgA test for diagnosing Mycobacterium avium complex infection in lung.
    Numata T; Araya J; Yoshii Y; Shimizu K; Hara H; Nakayama K; Kuwano K
    Respirology; 2015 Nov; 20(8):1277-81. PubMed ID: 26338466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of patients with bronchoscopy-diagnosed pulmonary Mycobacterium avium complex infection.
    Urabe N; Sakamoto S; Sano G; Ito A; Homma S
    J Infect Chemother; 2018 Oct; 24(10):822-827. PubMed ID: 30054229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
    Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
    Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.